Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/13/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company's website).

The teleconference will include a Company presentation followed by a question & answer period.

  • Date: Tuesday, November 14, 2017
  • Time: 4:30 PM Eastern Standard Time (EST)

To attend this teleconference live by telephone:
Dial-in: (877) 407-8031 (North America); (201) 689-8031 (International)
Verbal Passcode (to be given to the operator): PBIO Third Quarter 2017 Financial Call

For those unable to participate in the live teleconference, a replay will be available beginning Wednesday, November 15, 2017. The replay will be accessible both by telephone and through the Company's website for 30 days.

Replay Number: (877) 481-4010 (North America); (919) 882-2331 (Int'l); Replay ID Number: 22751

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities are emerging in the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water, fluoropolymers and alcohol, etc.), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

For more information about PBI and this press release, please click on the following link: http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:
Richard T. Schumacher
President & CEO
(T) 508-230-1828

Source: Pressure BioSciences, Inc.